San Diego, California--(Newsfile Corp. - February 3, 2026) - Johnson Fistel, PLLP is investigating whether PayPal Holdings, Inc. (NASDAQ: PYPL) or its executive officers complied with the federal securities laws. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.What if I purchased PayPal securities?If you purchased PayPal securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation.Or for mo ...

ATLANTA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ: RR) complied with federal securities laws. On January 29, 2026, Hunterbrook Media released a report alleging that “no material partnership appears to exist” between Richtech Robotics’ engineering team and Microsoft’s AI Co-Innovation Labs. Following this news, the price of the Company’s stock dropped. If you purchased Richtech stock and suffered a loss on tha ...

ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Travere Therapeutics, Inc. (“Travere” or the “Company”) (NASDAQ: TVTX) complied with federal securities laws. On January 13, 2026, Travere disclosed that the U.S. Food and Drug Administration has extended the review timeline of its supplemental New Drug Application for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis. Following this news, the price of the Company’s stock dropped. If you purchased Travere sto ...

Core Insights - Holzer & Holzer, LLC is investigating whether Aquestive Therapeutics, Inc. complied with federal securities laws following the FDA's notice regarding deficiencies in the New Drug Application for Anaphylm™ [1] - The FDA's notice indicates that the identified deficiencies preclude discussion of labeling and post-marketing commitments for Anaphylm™, which is intended for treating severe allergic reactions [1] - Following the FDA's announcement, the stock price of Aquestive Therapeutics experienced a decline [1] Company Information - Aquestive Therapeutics, Inc. is focused on developing treatments for severe allergic reactions, including anaphylaxis, through its product candidate Anaphylm™ [1] - Holzer & Holzer, LLC is a law firm that specializes in representing shareholders and investors in securities litigation, including class action and derivative litigation [3] - The firm has a history of recovering hundreds of millions of dollars for shareholders affected by corporate misconduct since its founding in 2000 [3]

Core Insights - Holzer & Holzer, LLC is investigating Ardent Health, Inc. for potential compliance issues with federal securities laws following a significant revenue decrease reported in Q3 2025 [1] - Ardent announced a revenue decrease of $43 million due to changes in accounting estimates related to accounts receivable collectability [1] Company Performance - In Q3 2025, Ardent Health reported a revenue decrease attributed to modifications in accounting techniques and new evaluations of historical collection trends [1] - The announcement of the revenue decrease led to a decline in the company's stock price [1]

Core Insights - Holzer & Holzer, LLC is investigating Stride, Inc. for potential violations of federal securities laws following a formal SEC complaint alleging fraud and deceptive practices [1] - The SEC complaint includes accusations of inflating student enrollment figures and prioritizing profit over compliance and student welfare [1] - Following the news of the SEC complaint, Stride's stock price experienced a decline [1] Company Overview - Stride, Inc. is publicly traded on the NYSE under the ticker symbol LRN [1] - The company is currently facing legal scrutiny due to allegations of systemic legal violations [1] Legal Context - The SEC complaint was filed by Gallup-McKinley, highlighting serious concerns regarding Stride's business practices [1] - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of representing shareholders in cases of corporate misconduct [3]

Core Insights - Holzer & Holzer, LLC is investigating RCI Hospitality Holdings, Inc. for potential violations of federal securities laws following the indictment of top executives for allegedly bribing an auditor to evade over $8 million in sales taxes from 2010 to 2024 [1] - The announcement of the indictment has led to a decline in RCI's stock price [1] Company Overview - RCI Hospitality Holdings, Inc. trades on NASDAQ under the ticker RICK [1] - The company is currently facing legal scrutiny due to allegations of corporate misconduct involving bribery [1] Legal Context - The New York Office of the Attorney General has initiated an investigation into RCI's executives, highlighting serious allegations of bribery related to tax evasion [1] - Holzer & Holzer, LLC is a law firm known for representing shareholders and investors in securities litigation, indicating a potential class action or derivative litigation against RCI [3]

Core Insights - Holzer & Holzer, LLC is investigating AVITA Medical, Inc. for potential compliance issues with federal securities laws following a significant drop in stock price after the company reported second quarter results and revised its 2025 guidance [1] - AVITA experienced a "significant headwind" due to a temporary gap in Medicare Administrative Contractor payments for its RECELL® System, which negatively impacted demand [1] Financial Performance - AVITA reported its second quarter 2025 results on August 7, 2025, indicating challenges in its operations [1] - The company revised its 2025 guidance, reflecting the impact of the payment gap on its financial outlook [1] Market Reaction - Following the announcement of the second quarter results and the revised guidance, AVITA's stock price experienced a decline [1]